Skip to main content

Get Social

Facebook Posts

HOPE!Ellipses Pharma Study to determine if a second generation RET inhibitor is a safe and possibly effective treatment for patients with RET-altered solid tumors.clinicaltrials.gov/ct2/show/NCT05443126 ... See MoreSee Less
View on Facebook
Cheers to a happy and healthy 2023!#lungcancer #cancerresearch #RETcancer #happylungs ... See MoreSee Less
View on Facebook
2022 RET Cancer Research Update (Watch Video)The Happy Lungs Project hosted a 2022 Research Update, featuring presentations about advances for RET-positive non-small cell lung cancer (NSCLC) from:- Dr. John Heymach, Chair of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center- Dr. Alexandre Reuben, Associate Professor, Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center#retcancerresearch #lungcancer #happylungsproject #cancerresearch #lungcancerresearchhappylungsproject.org/virtual-event-2022-research-update-watch-video/ ... See MoreSee Less
View on Facebook
Save the Date! 12/8 at 4pm CST. Learn about the progress we have made in our medical research for RET-positive cancer.RSVP HERE: forms.gle/fHd5GCRN86dMimX39#lungcancer #cancerresearch #RETcancer #happylungs #mdandersoncancercenter ... See MoreSee Less
View on Facebook

Your support saves lives.